help button home button
AJRCCM
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH
Published ahead of print on July 8, 2004, doi:10.1164/rccm.200403-346OC

Am. J. Respir. Crit. Care Med., Volume 170, Number 7, October 2004, 786-792

A more recent version of this article appeared on October 1, 2004
This Article
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
200403-346OCv1
170/7/786    most recent
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Combes, A.
Right arrow Articles by Chastre, J.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Combes, A.
Right arrow Articles by Chastre, J.

Submitted on March 16, 2004
Accepted on July 7, 2004

Impact of Methicillin Resistance on Outcome of Staphylococcus aureus Ventilator-associated Pneumonia

Alain Combes1*, Charles-Edouard Luyt1, Jean-Yves Fagon2, Michel Wollf3, Jean-Louis Trouillet1, Claude Gibert1, and Jean Chastre1

1 Service de Reanimation Medicale, Hopital Pitie-Salpetriere, Paris, France, 2 Service de Reanimation Medicale, Hopital Europeen Georges-Pompidou, Paris, France, 3 Service de Reanimation Medicale, Hopital Bichat-Claude-Bernard Assistance Publique-Hopitaux de Paris, Paris, France

* To whom correspondence should be addressed. E-mail: alain.combes{at}psl.ap-hop-paris.fr.

The impact of methicillin resistance on morbidity and mortality of patients suffering from severe Staphylococcus aureus infections remains highly controversial. We analyzed a retrospective cohort of 97 patients with methicillin-susceptible and 74 patients with methicillin-resistant Staphylococcus aureus ventilator-associated pneumonia. Initial empiric antibiotic therapy was appropriate for every patient. Patients with methicillin-resistant Staphylococcus aureus ventilator-associated pneumonia were older, had higher disease-severity scores and had been on mechanical ventilation longer at ventilator-associated pneumonia onset. Factors associated with 28-day death retained by multivariate logistic regression analysis were: age (OR = 1.05, 95% CI, 1.02-1.08, p = 0.001) and day-1 ODIN score (OR = 1.90, 95% CI, 1.31-2.78, p = 0.001), but not methicillin resistance (OR = 1.72, 95% CI, 0.73-4.05, p = 0.22). The percentages of infection relapse or superinfection did not differ significantly between the 2 patient groups. In conclusion, after controlling for clinical and physiologic heterogeneity between groups, methicillin resistance did not significantly affect 28-day mortality of patients with Staphylococcus aureus ventilator-associated pneumonia receiving appropriate antibiotics.
Key words: Antibiotic-Resistant Bacteria, Respiration, Artificial, Outcome Assessment, Multivariate Models




This article has been cited by other articles:


Home page
 Infect. Immun.Home page
A. Craig, J. Mai, S. Cai, and S. Jeyaseelan
Neutrophil Recruitment to the Lungs during Bacterial Pneumonia
Infect. Immun., February 1, 2009; 77(2): 568 - 575.
[Full Text] [PDF]

Home page
 J Antimicrob ChemotherHome page
R. G. Masterton, A. Galloway, G. French, M. Street, J. Armstrong, E. Brown, J. Cleverley, P. Dilworth, C. Fry, A. D. Gascoigne, et al.
Guidelines for the management of hospital-acquired pneumonia in the UK: Report of the Working Party on Hospital-Acquired Pneumonia of the British Society for Antimicrobial Chemotherapy
J. Antimicrob. Chemother., July 1, 2008; 62(1): 5 - 34.
[Abstract] [Full Text] [PDF]

Home page
 Eur Respir JHome page
Z. Athanassa, I. I. Siempos, and M. E. Falagas
Impact of methicillin resistance on mortality in Staphylococcus aureus VAP: a systematic review
Eur. Respir. J., March 1, 2008; 31(3): 625 - 632.
[Abstract] [Full Text] [PDF]

Home page
 Mayo Clin Proc.Home page
E. E. Hill, S. Vanderschueren, J. Verhaegen, P. Herijgers, P. Claus, M.-C. Herregods, and W. E. Peetermans
Risk Factors for Infective Endocarditis and Outcome of Patients With Staphylococcus aureus Bacteremia
Mayo Clin. Proc., October 1, 2007; 82(10): 1165 - 1169.
[Abstract] [Full Text] [PDF]

Home page
 The Annals of PharmacotherapyHome page
D. O Maclayton and R. G Hall II
Pharmacologic Treatment Options for Nosocomial Pneumonia Involving Methicillin-Resistant Staphylococcus aureus
Ann. Pharmacother., February 1, 2007; 41(2): 235 - 244.
[Abstract] [Full Text] [PDF]

Home page
 ChestHome page
M. N. Jeffres, W. Isakow, J. A. Doherty, P. S. McKinnon, D. J. Ritchie, S. T. Micek, and M. H. Kollef
Predictors of Mortality for Methicillin-Resistant Staphylococcus aureus Health-Care-Associated Pneumonia: Specific Evaluation of Vancomycin Pharmacokinetic Indices.
Chest, October 1, 2006; 130(4): 947 - 955.
[Abstract] [Full Text] [PDF]

Home page
 ChestHome page
C. A. DeRyke, T. P. Lodise Jr., M. J. Rybak, and P. S. McKinnon
Epidemiology, Treatment, and Outcomes of Nosocomial Bacteremic Staphylococcus aureus Pneumonia
Chest, September 1, 2005; 128(3): 1414 - 1422.
[Abstract] [Full Text] [PDF]

Home page
 Am. J. Respir. Crit. Care Med.Home page
D. Angus, A. Ishizaka, M. Matthay, F. Lemaire, W. MacNee, and E. Abraham
Critical Care in AJRCCM 2004
Am. J. Respir. Crit. Care Med., March 15, 2005; 171(6): 537 - 544.
[Full Text] [PDF]

Home page
 Journal of Pharmacy PracticeHome page
S. A. Voils, K. S. Kim, and E. T. Wittbrodt
Recent Trends in the Management of Ventilator-Associated Pneumonia
Journal of Pharmacy Practice, February 1, 2005; 18(1): 53 - 62.
[Abstract] [PDF]


HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH
Proc. Am. Thorac. Soc. Am. J. Respir. Cell Mol. Biol.
Copyright © 2004 American Thoracic Society 		  Work-Life